Chitosan-Coated Alginate Microcapsules of a Full-Spectrum Cannabis Extract: Characterization, Long-Term Stability and In Vitro Bioaccessibility
Pharmaceutics · 07.03.2023 · 15 (3) · 859
DOI: 10.3390/pharmaceutics15030859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.03.2023. Verfasst von Aitor Villate und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Basque Country, Spain. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Basque Government through the financial support as consolidated group of the Basque Research System.
Abstract (Originalsprache)
Cannabinoids present in Cannabis sativa are increasingly used in medicine due to their therapeutic potential. Moreover, the synergistic interaction between different cannabinoids and other plant constituents has led to the development of full-spectrum formulations for therapeutic treatments. In this work, the microencapsulation of a full-spectrum extract via vibration microencapsulation nozzle technique using chitosan-coated alginate is proposed to obtain an edible pharmaceutical-grade product. The suitability of microcapsules was assessed by their physicochemical characterization, long-term stability in three different storage conditions and in vitro gastrointestinal release. The synthetized microcapsules contained mainly ∆9-tetrahydrocannabinol (THC)-type and cannabinol (CBN)-type cannabinoids and had a mean size of 460 ± 260 µm and a mean sphericity of 0.5 ± 0.3. The stability assays revealed that capsules should be stored only at 4 °C in darkness to maintain their cannabinoid profile. In addition, based on the in vitro experiments, a fast intestinal release of cannabinoids ensures a medium–high bioaccessibility (57–77%) of therapeutically relevant compounds. The full characterization of microcapsules indicates that they could be used for the design of further full-spectrum cannabis oral formulations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Analytical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Basque Country, Spain.
- Research Centre for Experimental Marine Biology and Biotechnology (PIE), University of the Basque Country (UPV/EHU), 48620 Plentzia, Basque Country, Spain.
- Sovereign Fields S.L., Larramendi Kalea 3, 20006 Donostia, Basque Country, Spain.
ORCID-Profile: Aitor Villate, Oier Aizpurua-Olaizola
Förderung
- the Basque Government through the financial support as consolidated group of the Basque Research System
Zitieren
APA
Villate, A., San Nicolas, M., Olivares, M., Aizpurua-Olaizola, O., & Usobiaga, A. (2023). Chitosan-Coated Alginate Microcapsules of a Full-Spectrum Cannabis Extract: Characterization, Long-Term Stability and In Vitro Bioaccessibility. Pharmaceutics, 15(3), 859. https://doi.org/10.3390/pharmaceutics15030859
Vancouver
Villate A, San Nicolas M, Olivares M, Aizpurua-Olaizola O, Usobiaga A. Chitosan-Coated Alginate Microcapsules of a Full-Spectrum Cannabis Extract: Characterization, Long-Term Stability and In Vitro Bioaccessibility. Pharmaceutics. 2023;15(3):859. doi:10.3390/pharmaceutics15030859
BibTeX
@article{Villate2023,
author = {Villate, Aitor and San Nicolas, Markel and Olivares, Maitane and Aizpurua-Olaizola, Oier and Usobiaga, Aresatz},
title = {Chitosan-Coated Alginate Microcapsules of a Full-Spectrum Cannabis Extract: Characterization, Long-Term Stability and In Vitro Bioaccessibility},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {3},
pages = {859},
doi = {10.3390/pharmaceutics15030859}
}
EUVIMED